Missing Links? Citation Matrix Graphs Glossary  HistCite Guide  About
Mon Feb 21 09:50:33 2005
A molecular signature of metastasis in primary solid tumors
Ramaswamy S, Ross KN, Lander ES, Golub TR
NATURE GENETICS
33 (1): 49-54 JAN 2003
and the citing papers

Nodes: 212, Authors: 1098, Journals: 111, Outer References: 8910, Words: 854
Collection span: 2003 - 2005
View: Overview. Sorted by first author.
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
113670 2004 BRITISH JOURNAL OF CANCER 90(3):686-692
Adib TR; Henderson S; Perrett C; Hewitt D; Bourmpoulia D; et al.
Predicting biomarkers for ovarian cancer using gene-expression microarrays
03
222163 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 325(3):784-791
Albanese I; Scibetta AG; Migliavacca M; Russo A; Bazan V; et al.
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations
00
3116247 2003 NATURE GENETICS 34(4):369-376
Albertson DG; Collins C; McCormick F; Gray JW
Chromosome aberrations in solid tumors
531
459179 2004 CANCER CELL 6(1):17-32
Allinen M; Beroukhim R; Cai L; Brennan C; Lahti-Domenici J; et al.
Molecular characterization of the tumor microenvironment in breast cancer
07
516120 2003 EMBO REPORTS 4(12):1127-1131
Argraves WS; Greene LM; Cooley MA; Gallagher WM
Fibulins: physiological and disease perspectives
02
6158166 2004 MOLECULAR AND CELLULAR BIOLOGY 24(19):8662-8670
Astrof S; Crowley D; George EL; Fukuda T; Sekiguchi K; et al.
Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis
00
7124186 2004 ONCOLOGY REPORTS 11(3):677-680
Bauer M; Aust G; Schumacher U
Different transcriptional expression of KIAA1324 and its splicing variants in human carcinoma cell lines with different metastatic capacity
00
81251 2003 NATURE REVIEWS GENETICS 4(2):84-84
Baxter C
Molecular signatures
00
9145212 2005 PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS 348:349-370
Blasi MF; Casorelli I; Colosimo A; Blasi FS; Bignami M; et al.
A recursive network approach can identify constitutive regulatory circuits in gene expression data
00
1012081 2004 CANCER RESEARCH 64(7):2469-2473
Bockhorn M; Roberge S; Sousa C; Jain RK; Munn LL
Differential gene expression in metastasizing cells shed from kidney tumors
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
11144159 2004 JOURNAL OF MOLECULAR ENDOCRINOLOGY 33(3):663-677
Boelaert K; Yu R; Tannahill LA; Stratford AL; Khanim FL; et al.
PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro
00
12214252 2003 ONCOGENE 22(42):6524-6536
Bogenrieder T; Herlyn M
Axis of evil: molecular mechanisms of cancer metastasis
129
1312587 2004 CANCER RESEARCH 64(19):6973-6977
Brabletz T; Spaderna S; Kolb J; Hlubek F; Faller G; et al.
Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: An active role for the tumor environment in malignant tumor progression
00
1418626 2003 GENETICS 165(3):997-1015
Breitkreutz A; Boucher L; Breitkreutz BJ; Sultan M; Jurisica I; et al.
Phenotypic and transcriptional plasticity directed by a yeast mitogen-activated protein kinase network
04
15145178 2004 NEW ENGLAND JOURNAL OF MEDICINE 350(16):1605-1616
Bullinger L; Dohner K; Bair E; Frohling S; Schlenk RF; et al.
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia
230
16271122 2004 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 4(5):599-607
Bustin SA; Dorudi S
Gene expression profiling for molecular staging and prognosis prediction in colorectal cancer
00
17132134 2004 INTERNATIONAL JOURNAL OF CANCER 108(3):412-417
Bustin SA; Siddiqi S; Ahmed S; Hands R; Dorudi S
Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients
12
18192167 2004 MOLECULAR AND CELLULAR BIOLOGY 24(22):9705-9725
Cao XH; Liu W; Lin F; Li H; Kolluri SK; et al.
Retinoid X receptor regulates Nur77/thyroid hormone receptor 3-dependent apoptosis by modulating its nuclear export and mitochondrial targeting
01
19128203 2005 BLOOD 105(2):821-826
Cario G; Stanulla M; Fine BM; Teuffel O; Neuhoff NV; et al.
Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia
00
20223201 2005 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 326(2):268-273
Chan BCL; Li Q; Chow SKY; Ching AKK; Liew CT; et al.
BRE enhances in vivo growth of tumor cells
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
21136163 2004 LEUKEMIA 18(3):556-565
Choi YL; Makishima H; Ohashi J; Yamashita Y; Ohki R; et al.
DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3(-)CD56(+) fractions
01
2214578 2004 CANCER CELL 5(5):489-500
Chung CH; Parker JS; Karaca G; Wu JY; Funkhouser WK; et al.
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression
03
23273209 2005 JOURNAL OF UROLOGY 173(1):10-20
Chung LWK; Baseman A; Assikis V; Zhau HE
Molecular insights into prostate cancer progression: The missing link of tumor microenvironment
00
2412112 2003 CANCER RESEARCH 63(18):5669-5673
Collisson EA; De A; Suzuki H; Gambhir SS; Kolodney MS
Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade
08
25482136 2004 INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY 48(5-6):573-581
Crnic I; Christofori G
Novel technologies and recent advances in metastasis research
00
2624194 2004 CARCINOGENESIS 25(7):1157-1163
Cuezva JM; Chen G; Isidoro A; Misek DE; Hanash SM; et al.
The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis
00
271383 2003 BMC BIOINFORMATICS 4
Culhane AC; Perriere G; Higgins DG
Cross-platform comparison and visualisation of gene expression data using co-inertia analysis
01
2812473 2004 BRITISH JOURNAL OF CANCER 90(8):1577-1582
Dawson LA; Maitland NJ; Turner AJ; Usmani BA
Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression
00
29144139 2004 INTERNATIONAL JOURNAL OF ONCOLOGY 24(5):1279-1288
De Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; et al.
Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil
01
303135179 2004 ONCOGENE 23(18):3189-3199
De Benedetti A; Graff JR
eIF-4E expression and its role in malignancies and metastases
07
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
3122576 2004 BRITISH JOURNAL OF CANCER 91(6):1160-1165
De Smet F; Moreau Y; Engelen K; Timmerman D; Vergote I; et al.
Balancing false positives and false negatives for the detection of differential expression in malignancies
00
32261190 2004 PHARMACOGENOMICS JOURNAL 4(3):193-207
Debey S; Schoenbeck U; Hellmich M; Gathof BS; Pillai R; et al.
Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types
12
331175115 2004 CURRENT PHARMACEUTICAL DESIGN 10(31):3913-3928
Desnoyers L
Structural basis and therapeutic implication of the interaction of CCN proteins with glycoconjugates
01
3414625 2003 FEBS LETTERS 546(1):98-102
Detours V; Dumont JE; Bersini H; Maenhaut C
Integration and cross-validation of high-throughput gene expression data: comparing heterogeneous data sets
17
3513333 2003 JOURNAL OF EXPERIMENTAL MEDICINE 198(11):1753-1757
Dhodapkar MV; Krasovsky J; Osman K; Geller MD
Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy
04
3617850 2003 NATURE REVIEWS CANCER 3(12):903-911
di Magliano MP; Hebrok M
Hedgehog signalling in cancer formation and maintenance
012
3717622 2003 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 3(3):375-385
Dobrin SE; Stephan DA
Integrating microarrays into disease-gene identification strategies
03
38146131 2004 GYNECOLOGIC ONCOLOGY 95(3):437-448
Drew AF; Blick TJ; Lafleur MA; Tim ELM; Robbie MJ; et al.
Correlation of tumor-and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice
00
39322150 2004 JOURNAL OF CLINICAL ONCOLOGY 22(16):3209-3211
Dubinett SM; Elashoff D; Meyerson M
Assessing prognosis in non-small-cell lung cancer: Avenues to a more complete picture?
00
4018624 2003 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 3(5):635-647
Dyrskjot L
Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics
03
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
41132202 2005 BIOINFORMATICS 21(2):171-178
Ein-Dor L; Kela I; Getz G; Givol D; Domany E
Outcome signature genes in breast cancer: is there a unique set?
00
42144148 2004 JOURNAL OF CLINICAL ONCOLOGY 22(5):811-819
Endoh H; Tomida S; Yatabe Y; Konishi H; Osada H; et al.
Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction
11
43122182 2004 ONCOGENE 23(31):5371-5377
Erez A; Perelman M; Hewitt SM; Cojacaru G; Goldberg I; et al.
Sil overexpression in lung cancer characterizes tumors with increased mitotic activity
01
44120198 2004 SURGERY 136(3):500-503
Eschrich S; Yeatman TJ
DNA microarrays and data analysis: An overview
00
45145170 2004 NATURE CELL BIOLOGY 6(6):507-514
Eustace BK; Sakurai T; Stewart JK; Yimlamai D; Unger C; et al.
Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness
15
46110536 2003 JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA 8(1):75-89
Fackler MJ; Evron E; Khan SA; Sukumar S
Novel agents for chemoprevention, screening methods, and sampling issues
01
4719038 2003 JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA 8(3):321-334
Fargiano AA; Desai KV; Green JE
Interrogating mouse mammary cancer models: Insights from gene expression profiling
00
4812539 2003 JOURNAL OF UROLOGY 170(6):S11-S19
Febbo PG; Sellers WR
Use of expression analysis to predict outcome after radical prostatectomy
00
49129157 2004 JOURNAL OF IMMUNOLOGY 172(11):7103-7109
Feezor RJ; Baker HV; Xiao WH; Lee WA; Huber TS; et al.
Genomic and proteomic determinants of outcome in patients undergoing thoracoabdominal aortic aneurysm repair
00
50470200 2004 TRENDS IN MOLECULAR MEDICINE 10(8):387-392
Fong S; Debs RJ; Desprez PY
Id genes and proteins as promising targets in cancer therapy
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
51273158 2004 JOURNAL OF MEDICAL GENETICS 41(1):1-5
Foulkes WD
BRCA1 functions as a breast stem cell regulator
15
521235 2003 CANCER 98(8):1569-1577
Foulkes WD; Metcalfe K; Hanna W; Lynch HT; Ghadirian P; et al.
Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma
25
531136 2003 CANCER 98(12):2687-2692
Fuchs B; Valenzuela RG; Inwards C; Sim FH; Rock MG
Complications in long-term survivors of Ewing sarcoma
04
54222107 2004 CLINICAL CANCER RESEARCH 10(10):3457-3464
Gangnus R; Langer S; Breit E; Pantel K; Speicher MR
Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients
11
5512219 2003 DRUG NEWS & PERSPECTIVES 16(4):217-221
Gant TW
Application of toxicogenomics in drug development
03
56170110 2004 COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING 7(1):1-9
Gerner C
Screening for disease-markers and investigating drug effects by proteome profiling: Can it meet expectations?
00
57130147 2004 JOURNAL OF CLINICAL INVESTIGATION 113(6):913-923
Glinsky GV; Glinskii AB; Stephenson AJ; Hoffman RM; Gerald WL
Gene expression profiling predicts clinical outcome of prostate cancer
04
58110323 2003 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 3(4):431-442
Goessl C
Diagnostic potential of circulating nucleic acids for oncology
00
59165137 2004 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 13(4):483-495
Goldsmith ZG; Dhanasekaran N
The microrevolution: Applications and impacts of microarray technology on molecular biology and medicine (Review)
00
60111015 2003 CLINICAL & EXPERIMENTAL METASTASIS 20(3):265-273
Graff JR; Zimmer SG
Translational control and metastatic progression: Enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs
319
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
61252100 2004 CELL CYCLE 3(6):718-721
Grego-Bessa J; Diez J; Timmerman L; de la Pompa JL
Notch and epithelial-mesenchyme transition in development and tumor progression - Another turn of the screw
00
62151126 2004 GENOME BIOLOGY 5(5)
Grigoryev DN; Ma SF; Irizarry RA; Ye SQ; Quackenbush J; et al.
Orthologous gene-expression profiling in multi-species models: search for candidate genes
01
63117127 2004 GENOME BIOLOGY 5(6)
Grose R
Common ground in the transcriptional profiles of wounds and tumors
00
6415396 2004 CARCINOGENESIS 25(12):2293-2301
Gu B; Espana L; Mendez O; Torregrosa A; Sierra A
Organ-selective chemoresistance in metastasis from human breast cancer cells: inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus
00
65121135 2004 INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY 48(5-6):457-462
Hart IR; Fidler IJ
From here to there; a life based on migration - An interview with Isaiah J. Fidler
00
66126154 2004 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 23(3):513-520
Hata F; Nishimori H; Yasoshima T; Tanaka H; Ohno K; et al.
Profiling analysis of differential gene expression between hematogenous and peritoneal metastatic sublines of human pancreatic cancer using a DNA chip
00
677108121 2004 EXPERT OPINION ON THERAPEUTIC TARGETS 8(6):527-536
Hedley BD; Winquist E; Chambers AF
Therapeutic targets for antimetastatic therapy
00
6812516 2003 CURRENT OPINION IN CELL BIOLOGY 15(5):640-644
Houshmand P; Zlotnik A
Targeting tumor cells
01
6914118 2003 DRUG DISCOVERY TODAY 8(8):356-363
Huang Y; Sadee W
Drug sensitivity and resistance genes in cancer chemotherapy: a chemogenomics approach
17
701946 2003 NATURE GENETICS 34(1):23-24
Hunter K; Welch DR; Liu ET
Genetic background is an important determinant of metastatic potential
69
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
7125610 2003 CANCER LETTERS 200(2):97-105
Hunter KW
Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination
13
7233571 2004 BRITISH JOURNAL OF CANCER 90(4):752-755
Hunter KW
Host genetics and tumour metastasis
25
7331914 2003 CELL 113(7):821-823
Hynes RO
Metastatic potential: Generic predisposition of the primary tumor or rare, metastatic variants - or both?
511
741575 2004 BRITISH JOURNAL OF CANCER 91(4):813-813
Iizuka N; Oka M
CIITA methylation and decreased levels of HLA-DR in tumour progression
00
7522564 2004 BIOCHEMICAL JOURNAL 378:17-20
Isidoro A; Martinez M; Fernandez PL; Ortega AD; Santamaria G; et al.
Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer
00
7629037 2003 JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA 8(3):257-268
Jacobsen BM; Richer JK; Sartorius CA; Horwitz KB
Expression profiling of human breast cancers and gene regulation by progesterone receptors
00
7723785 2004 CANCER RESEARCH 64(11):3907-3913
Jain SJ; Watson MA; DeBenedetti MK; Hiraki Y; Moley JF; et al.
Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors
04
781734 2003 BREAST CANCER RESEARCH 5(6):320-328
Jeffrey SS; Pollack JR
The diagnosis and management of pre-invasive breast disease - Promise of new technologies in understanding pre-invasive breast lesions
04
7911665 2004 BMC BIOINFORMATICS 5
Jiang HY; Deng YP; Chen HS; Tao L; Sha QY; et al.
Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes
01
80143184 2004 ONCOGENE 23(40):6830-6844
Jinawath N; Furukawa Y; Hasegawa S; Li MH; Tsunoda T; et al.
Comparison of gene-expression profiles between diffuse-and intestinal-type gastric cancers using a genome-wide cDNA microarray
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
81126141 2004 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 291(22):2713-2719
Johansson JE; Andren O; Andersson SO; Dickman PW; Holmberg L; et al.
Natural history of early, localized prostate cancer
09
8213241 2003 LUNG CANCER 41:S3-S8
Johnson DH
Targeted therapy in non-small cell lung cancer: myth or reality
01
8313684 2004 CANCER RESEARCH 64(9):3037-3045
Jones C; Mackay A; Grigoriadis A; Cossu A; Reis-Filho JS; et al.
Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer
04
84122162 2004 LANCET 363(9411):775-781
Jones MH; Virtanen C; Honjoh D; Miyoshi T; Satoh Y; et al.
Two prognostically significant subtypes of high-grade lung neuroendocrine turnours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles
04
85180118 2004 EUROPEAN JOURNAL OF BIOCHEMISTRY 271(11):2189-2203
Joshi B; Cameron A; Jagus R
Characterization of mammalian eIF4E-family members
02
86115432 2003 JOURNAL OF CLINICAL INVESTIGATION 112(12):1776-1784
Kalluri R; Neilson EG
Epithelial-mesenchymal transition and its implications for fibrosis
019
87123104 2004 CHEST 125(5):111S-115S
Kaminski N; Krupsky M
Gene expression patterns, prognostic and diagnostic markers, and lung cancer biology
00
8824721 2003 EXPERIMENTAL AND MOLECULAR MEDICINE 35(6):556-564
Kang KR; Chung SI
Protein kinase CK2 phosphorylates and interacts wit deoxyhypusine synthase in HeLa cells
00
8931998 2004 CELL 118(3):277-279
Kang YB; Massague J
Epithelial-mesenchymal transitions: Twist in development and metastasis
01
901507 2003 CANCER CELL 3(6):537-549
Kang YB; Siegel PM; Shu WP; Drobnjak M; Kakonen SM; et al.
A multigenic program mediating breast cancer metastasis to bone
2166
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
9124160 2004 ANNALS OF SURGICAL ONCOLOGY 11(8):727-730
Kappas AM; Fatouros M; Roukos DH
Is it time to change surgical strategy for gastric cancer in the United States?
00
9226561 2004 APPLICATIONS OF BIOINFORMATICS IN CANCER DETECTION 1020:92-100
Kawasaki ES
Microarrays and the gene expression profile of a single cell
00
93147112 2004 COMPARATIVE AND FUNCTIONAL GENOMICS 5(1):39-47
Khan HA
ArraySolver: an algorithm for colour-coded graphical display and Wilcoxon signed-rank statistics for comparing microarray gene expression data
11
94232207 2005 JOURNAL OF MOLECULAR BIOLOGY 345(4):645-649
Khan HA
ArrayVigil: A methodology for statistical comparison of gene signatures using segregated-one-tai led (SOT) Wilcoxon's signed-rank test
00
95127174 2004 NATURE MEDICINE 10(2):182-186
Khanna C; Wan XL; Bose S; Cassaday R; Olomu O; et al.
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
213
962124111 2004 COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING 7(3):183-206
Kim AS
Clinical impact of gene expression profiling on oncology diagnosis, prognosis, and treatment
01
9711341 2003 ADVANCES IN CANCER RESEARCH, VOL 89 89:35-67
Klein CA
The systemic progression of human cancer: A focus on the individual disseminated cancer cell - The unit of selection
12
9842799 2004 CELL CYCLE 3(1):29-31
Klein CA
Gene expression signatures, cancer cell evolution and metastatic progression
01
99334205 2005 GENES CHROMOSOMES & CANCER 42(3):299-307
Kohlmann A; Schoch C; Dugas M; Rauhut S; Weninger F; et al.
Pattern robustness of diagnostic gene expression signatures in leukemia
00
100267196 2004 SEMINARS IN ONCOLOGY 31(1):39-53
Kohn EC; Lu YL; Wang HW; Yu QH; Yu SX; et al.
Molecular therapeutics: Promise and challenges
01
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
101183120 2004 EXPERIMENTAL DERMATOLOGY 13(10):593-606
Kunz M; Ibrahim SM; Koczan D; Scheid S; Thiesen HJ; et al.
DNA microarray technology and its applications in dermatology
00
102167142 2004 JOURNAL OF BIOMEDICAL INFORMATICS 37(4):293-303
Kuo WP; Kim EY; Trimarchi J; Jenssen TK; Vinterbo SA; et al.
A primer on gene expression and microarrays for machine learning researchers
00
103244109 2004 CLINICAL CANCER RESEARCH 10(18):6029-6038
Kurokawa Y; Matoba R; Nagano H; Sakon M; Takemasa I; et al.
Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma
00
104249155 2004 JOURNAL OF HEPATOLOGY 41(2):284-291
Kurokawa Y; Matoba R; Takemasa I; Nagano H; Dono K; et al.
Molecular-based prediction of early recurrence in hepatocellular carcinoma
14
10514734 2003 JOURNAL OF HEPATOLOGY 39(6):1004-1012
Kurokawa Y; Matoba R; Takemasa I; Nakamori S; Tsujie M; et al.
Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study
12
1063255116 2004 ENDOCRINE-RELATED CANCER 11(3):497-522
Lacroix M; Toillon RA; Leclercq G
Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics
00
107120140 2004 INTERNATIONAL JOURNAL OF ONCOLOGY 24(6):1589-1596
Lahdesmaki H; Hao XS; Sun BC; Hu LM; Yli-Harja O; et al.
Distinguishing key biological pathways between primary breast cancers and their lymph node metastases by gene function-based clustering analysis
00
108142191 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(3):811-816
Lapointe J; Li C; Higgins JP; van de Rijn M; Bair E; et al.
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
214
109293129 2004 GENOME RESEARCH 14(6):1085-1094
Lee HK; Hsu AK; Sajdak J; Qin J; Pavlidis P
Coexpression analysis of human genes across many microarray data sets
00
11022088 2004 CANCER RESEARCH 64(20):7201-7204
Lee YF; John M; Falconer A; Edwards S; Clark J; et al.
A gene expression signature associated with metastatic outcome in human leiomyosarcomas
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
111134123 2004 FEBS LETTERS 556(1-3):221-226
Lener T; Burgstaller G; Gimona M
The role of calponin in the gene profile of metastatic cells: inhibition of metastatic cell motility by multiple calponin repeats
01
112122138 2004 INTERNATIONAL JOURNAL OF ONCOLOGY 24(2):305-312
Li MH; Lin YM; Hasegawa S; Shimokawa T; Murata K; et al.
Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray
01
113237143 2004 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 130(8):460-468
Li Y; Tian B; Yang J; Zhao L; Wu X; et al.
Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics
00
11412811 2003 CANCER RESEARCH 63(16):4781-4785
Lieberfarb ME; Lin M; Lechpammer M; Li C; Tanenbaum DM; et al.
Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP
113
115164108 2004 CLINICAL CANCER RESEARCH 10(12):3980-3987
Lim YP; Wong CY; Ooi LL; Druker BJ; Epstein RJ
Selective tyrosine hyperphosphorylation of cytoskeletal and stress proteins in primary human breast cancers: Implications for adjuvant use of kinase-inhibitory drugs
00
1161100151 2004 JOURNAL OF CLINICAL ONCOLOGY 22(17):3608-3617
Lin NU; Bellon JR; Winer EP
CNS metastases in breast cancer
00
1171544 2003 NATURE GENETICS 33(1):10-11
Liotta LA; Kohn EC
Cancer's deadly signature
912
118460189 2004 PHARMACOGENOMICS 5(8):1117-1128
Liu ET
Expression genomics and cancer biology
00
11915135 2003 JOURNAL OF IMMUNOLOGY 171(8):4164-4174
Liu KB; McDuffie E; Abrams SI
Exposure of human primary colon carcinoma cells to anti-Fas interaction influences the emergence of pre-existing Fas-resistant metastatic subpopulations
01
120523102 2004 CELL CYCLE 3(10):1250-1251
Malins DC
Metastasizing and non-metastasizing tumors likely evolve from DNA phenotypes via independent pathways
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
121222193 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(31):11428-11431
Malins DC; Gilman NK; Green VM; Wheeler TM; Barker EA; et al.
Metastatic cancer DNA phenotype identified in normal tissues surrounding metastasizing prostate carcinomas
11
122228199 2004 SURGERY 136(3):511-518
Matros E; Wang ZGC; Richardson AL; Iglehart JD
Genomic approaches in cancer biology
00
12314795 2004 CARCINOGENESIS 25(9):1599-1609
McArdle L; McDermott M; Purcell R; Grehan D; O'Meara A; et al.
Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q
00
124150171 2004 NATURE GENETICS 36(2):197-204
McCarroll SA; Murphy CT; Zou SG; Pletcher SD; Chin CS; et al.
Comparing genomic expression patterns across species identifies shared transcriptional profile in aging
013
125222105 2004 CLINICAL CANCER RESEARCH 10(9):3104-3109
Mehrotra J; Vali M; McVeigh M; Kominsky SL; Fackler MJ; et al.
Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung
01
126115031 2003 JOURNAL OF CLINICAL INVESTIGATION 112(11):1603-1618
Melmed S
Mechanisms for pituitary tumorigenesis: the plastic pituitary
04
1271140195 2004 SEMINARS IN ONCOLOGY 31(1):4-19
Meyerson M; Franklin WA; Kelley MJ
Molecular classification and molecular genetics of human lung cancers
14
128117210 2005 LANCET 365(9458):488-492
Michiels S; Koscielny S; Hill C
Prediction of cancer outcome with microarrays: a multiple random validation strategy
00
129318206 2005 JOURNAL OF CLINICAL INVESTIGATION 115(1):44-55
Minn AJ; Kang YB; Serganova I; Gupta GP; Giri DD; et al.
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
00
13017056 2003 TRENDS IN GENETICS 19(10):570-577
Moreau Y; Aerts S; De Moor B; De Strooper B; Dabrowski M
Comparison and meta-analysis of microarray data: from the bench to the computer desk
18
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
131121133 2004 INTERNATIONAL IMMUNOPHARMACOLOGY 4(14):1829-1836
Motomura K; Toyoda N; Oishi K; Sato H; Nagai S; et al.
Identification of a host gene subset related to disease prognosis of HIV-1 infected individuals
00
132133164 2004 LUNG CANCER 45:S145-S150
Muller-Tidow C; Diederichs S; Thomas M; Serve H
Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer
00
133127146 2004 JOURNAL OF CHEMOMETRICS 18(3-4):125-132
Musumarra G; Barresi V; Condorelli DF; Fortuna CG; Scire S
Potentialities of multivariate approaches in genome-based cancer research: identification of candidate genes for new diagnostics by PLS discriminant analysis
00
13414889 2004 CANCER RESEARCH 64(21):7813-7821
Nicholson BE; Frierson HF; Conaway MR; Seraj JM; Harding MA; et al.
Profiling the evolution of human metastatic bladder cancer
00
1351248 2003 NATURE REVIEWS CANCER 3(1):4-5
Novak K
Stay or go?
00
136136185 2004 ONCOGENE 23(55):8997-9006
Ohali A; Avigad S; Zaizov R; Ophir R; Horn-Saban S; et al.
Prediction of high risk Ewing's sarcoma by gene expression profiling
00
13712162 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 320(4):1328-1336
Ohki-Kaneda R; Ohashi J; Yamamoto K; Ueno S; Ota J; et al.
Cardiac function-related gene expression profiles in human atrial myocytes
00
138353175 2004 NATURE REVIEWS CANCER 4(6):448-456
Pantel K; Brakenhoff RH
Dissecting the metastatic cascade
14
139366132 2004 HUMAN MOLECULAR GENETICS 13(13):1303-1313
Paris PL; Andaya A; Fridlyand J; Jain AN; Weinberg V; et al.
Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors
01
14014230 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(35):32683-32691
Park JH; Wolff EC; Folk JE; Park MH
Reversal of the deoxyhypusine synthesis reaction - Generation of spermidine or homospermidine from deoxyhypusine by deoxyhypusine synthase
15
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
14112074 2004 BRITISH JOURNAL OF CANCER 90(10):1976-1982
Patmore HS; James NEA; Cawkwell L; MacDonald A; Stafford ND; et al.
Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation?
01
142110149 2003 NATURE REVIEWS CANCER 3(6):434-443
Perez-Losada J; Balmain A
Stem-cell hierarchy in skin cancer
031
143133177 2004 NEOPLASIA 6(6):744-750
Pilarsky C; Wenzig M; Specht T; Saeger HD; Grutzmann R
Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data
00
144334168 2004 MOLECULAR CANCER RESEARCH 2(10):551-556
Pinkas J; Martin SS; Leder P
Bcl-2-mediated cell survival promotes metastasis of EpH4 beta MEKDD mammary epithelial cells
00
14513791 2004 CANCER RESEARCH 64(24):8846-8853
Planaguma J; Diaz-Fuertes M; Gil-Moreno A; Abal M; Monge M; et al.
A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma
00
14613143 2003 MOLECULAR CANCER RESEARCH 1(5):362-375
Porter D; Lahti-Domenici J; Keshaviah A; Bae YK; Argani P; et al.
Molecular markers in ductal carcinoma in situ of the breast
328
1471236144 2004 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 130(9):497-513
Qin LX; Tang ZY
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature
00
14823886 2004 CANCER RESEARCH 64(17):5973-5981
Qiu TH; Chandramouli GVR; Hunter KW; Alkharouf NW; Green JE; et al.
Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: Correlation to human disease
12
1492742 2003 M S-MEDECINE SCIENCES 19(11):1050-1051
Raguenez G; Benard J
Molecular signature for cancer metastasis
00
15031977 2004 BULLETIN DU CANCER 91(2):129-132
Raguenez G; Blanc E; Benard J
Metastatic potential: a generic characteristic of the primary tumor
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
1512253180 2004 ONCOGENE 23(18):3248-3264
Rajasekhar VK; Holland EC
Postgenomic global analysis of translational control induced by oncogenic signaling
03
15211440 2003 LANCET 361(9369):1576-1577
Ramaswamy S; Perou CM
DNA microarrays in breast cancer: the promise of personalised medicine
17
15302945 2003 NATURE GENETICS 33(1):49-54
Ramaswamy S; Ross KN; Lander ES; Golub TR
A molecular signature of metastasis in primary solid tumors
211211
154122106 2004 CLINICAL CANCER RESEARCH 10(10):3422-3428
Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; et al.
Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells
11
155237183 2004 ONCOGENE 23(39):6684-6692
Reis EM; Nakaya HI; Louro R; Canavez FC; Flatschart AVF; et al.
Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer
00
156149192 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(25):9309-9314
Rhodes DR; Yu JJ; Shanker K; Deshpande N; Varambally R; et al.
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
16
15712657 2004 AMERICAN JOURNAL OF PATHOLOGY 164(1):23-33
Rook MS; Delach SM; Deyneko G; Worlock A; Wolfe JL
Whole genome amplification of DNA from laser capture-microdissected tissue for high-throughput single nucleotide polymorphism and short tandem repeat genotyping
03
158193165 2004 LUNG CANCER 46(2):135-148
Rosell R; Felip E; Garcia-Campelo R; Balana C
The biology of non-small-cell lung cancer: identifying new targets for rational therapy
00
15912659 2004 ANNALS OF SURGICAL ONCOLOGY 11(2):127-129
Roukos DH
Early-stage gastric cancer: A highly treatable disease
11
160159145 2004 JOURNAL OF CELL BIOLOGY 167(4):769-781
Sabeh F; Ota I; Holmbeck K; Birkedal-Hansen H; Soloway P; et al.
Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
16116458 2004 AMERICAN JOURNAL OF PATHOLOGY 164(3):903-914
Sato N; Fukushima N; Maitra A; Iacobuzio-Donahue CA; van Heek NT; et al.
Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas
04
16213172 2004 BRITISH JOURNAL OF CANCER 90(5):1041-1046
Savinainen KJ; Linja MJ; Saramaki OR; Tammela TLJ; Chang GTG; et al.
Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer
01
16316269 2004 BREAST CANCER RESEARCH 6(2):93-101
Schedin P; Elias A
Multistep tumorigenesis and the microenvironment
02
164430172 2004 NATURE GENETICS 36(10):1090-1098
Segal E; Friedman N; Koller D; Regev A
A module map showing conditional activity of expression modules in cancer
00
165136194 2004 PROTEOMICS 4(9):2776-2788
Seike M; Kondo T; Fujii K; Yamada T; Gemma A; et al.
Proteomic signature of human cancer cells
00
16614592 2004 CANCER RESEARCH 64(24):9209-9216
Shah RB; Mehra R; Chinnaiyan AM; Shen RL; Ghosh D; et al.
Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program
00
16719429 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 77(3):213-225
Shaughnessy JD
Global gene expression profiling in the study of multiple myeloma
01
168119827 2003 IMMUNOLOGICAL REVIEWS 194(1):140-163
Shaughnessy JD; Barlogie B
Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling
08
1691107176 2004 NATURE REVIEWS GENETICS 5(5):335-344
Shendure J; Mitra RD; Varma C; Church GM
Advanced sequencing technologies: Methods and goals
07
17022019 2003 CANCER LETTERS 198(1):1-20
Shevde LA; Welch DR
Metastasis suppressor pathways - an evolving paradigm
48
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
171174153 2004 JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY 23(1):13-31
Shioda T
Application of DNA microarray to toxicological research
01
17213228 2003 INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 84(4):173-183
Simpson PT; Shoker BS; Barraclough R; Halliwell N; Rudland PS; et al.
Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer
00
17334166 2004 BMC CANCER 4
Sloan KE; Eustace BK; Stewart JK; Zehetmeier C; Torella C; et al.
CD155/PVR plays a key role in cell motility during tumor cell invasion and migration
00
174148152 2004 JOURNAL OF CLINICAL ONCOLOGY 22(23):4648-4658
Spentzos D; Levine DA; Ramoni MF; Joseph M; Gu XS; et al.
Gene expression signature with independent prognostic significance in epithelial ovarian cancer
01
175115188 2004 PHARMACOGENOMICS 5(3):233-237
Stallings SC
Who'll be first? Genomic biomarkers impact on drug discovery and clinical practice
00
1761131113 2004 CURRENT DRUG TARGETS 5(4):333-346
Stein WD; Bates SE; Fojo T
Intractable cancers: The many faces of multidrug resistance and the many targets it presents for therapeutic attack
00
17726082 2004 CANCER RESEARCH 64(8):2805-2816
Stein WD; Litman T; Fojo T; Bates SE
Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: Comparing solid tumors with cell lines and comparing solid tumors from different tissue origins
03
178159117 2004 ENVIRONMENTAL HEALTH PERSPECTIVES 112(12):1236-1248
Steiner G; Suter L; Boess F; Gasser R; de Vera MC; et al.
Discriminating different classes of toxicants by transcript profiling
01
179197169 2004 NATURE 429(6990):469-474
Strausberg RL; Simpson AJG; Old LJ; Riggins GJ
Oncogenomics and the development of new cancer therapies
00
180152114 2004 CURRENT OPINION IN MOLECULAR THERAPEUTICS 6(6):593-599
Sultmann H; Poustka A
Recent advances in transcription profiling of human cancer
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
181246204 2005 CLINICAL CANCER RESEARCH 11(2):646-655
Sultmann H; von Heydebreck A; Huber W; Kuner R; Buness A; et al.
Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival
00
182257160 2004 JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY 25(4-5):303-308
Suyama E; Kawasaki H; Wadhwa R; Tajra K
Cell migration and metastasis as targets of small RNA-based molecular genetic analyses
00
183136211 2005 NATURE GENETICS 37(1):48-55
Sweet-Cordero A; Mukherjee S; Subramanian A; You H; Roix JJ; et al.
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis
01
1841792 2003 ADVANCES IN CANCER RESEARCH, VOL 89 89:157-181
Takahashi M; Sugimura J; Yang XM; Vogelzang N; Teh BS; et al.
Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics
05
1851167187 2004 ORAL ONCOLOGY 40(7):656-667
Takes RP
Staging of the neck in patients with head and neck squamous cell cancer: Imaging techniques and biomarkers
00
186135149 2004 JOURNAL OF CLINICAL ONCOLOGY 22(13):2671-2680
Takeuchi H; Morton DL; Kuo C; Turner RR; Elashoff D; et al.
Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients
01
187129197 2004 SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND 2(1):1-6
Thompson AM
Dissecting the molecular mechanisms of human cancer: Translating laboratory advances into clinical practice
00
188121953 2003 PATHOLOGY & ONCOLOGY RESEARCH 9(1):49-72
Timar J; Ladanyi A; Petak I; Jeney A; Kopper L
Molecular pathology of tumor metastasis III - Target array and combinatorial therapies
02
189168125 2004 GENES & DEVELOPMENT 18(1):99-115
Timmerman LA; Grego-Bessa J; Raya A; Bertran E; Perez-Pomares JM; et al.
Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation
17
190137181 2004 ONCOGENE 23(31):5360-5370
Tomida S; Koshikawa K; Yatabe Y; Harano T; Ogura N; et al.
Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
191139130 2004 GYNECOLOGIC ONCOLOGY 92(2):559-567
Torng PL; Mao TL; Chan WY; Huang SC; Lin CT
Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression
01
192141128 2004 GENOME BIOLOGY 5(8)
Trainer AH
Molecular tumor profiling: translating genomic insights into clinical advances
00
193141156 2004 JOURNAL OF HEPATOLOGY 41(3):399-406
Utsunomiya T; Okamoto M; Hashimoto M; Yoshinaga K; Shiraishi T; et al.
A gene-expression signature can quantify the degree of hepatic fibrosis in the rat
01
194148208 2005 JOURNAL OF ORAL PATHOLOGY & MEDICINE 34(2):77-86
Vigneswaran N; Wu J; Sacks P; Gilcrease M; Zacharias W
Microarray gene expression profiling of cell lines from primary and metastatic tongue squamous cell carcinoma: possible insights from emerging technology
00
1951111124 2004 FRONTIERS IN BIOSCIENCE 9:1023-1034
Vincan E
Frizzled/WNT signalling: The insidious promoter of tumour growth and progression
01
1961808 2003 CANCER CELL 4(3):209-221
Wang SY; Gao J; Lei QY; Rozengurt N; Pritchard C; et al.
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
124
19725990 2004 CANCER RESEARCH 64(23):8585-8594
Wang WG; Goswami S; Lapidus K; Wells AL; Wyckoff JB; et al.
Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors
00
19812467 2004 BRAIN PATHOLOGY 14(3):297-303
Watson MA; Perry A; Tihan T; Prayson RA; Guha A; et al.
Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors
00
19922754 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(26):15901-15905
Weigelt B; Glas AM; Wessels LFA; Witteveen AT; Peterse JL; et al.
Gene expression profiles of primary breast tumors maintained in distant metastases
611
200218101 2004 CELL CYCLE 3(6):756-757
Weigelt B; van't Veer LJ
Hard-wired genotype in metastatic breast cancer
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
20152868 2004 BREAST CANCER RESEARCH 6(2):61-64
Welch DR
Microarrays bring new insights into understanding of breast cancer metastasis to bone
12
20216655 2003 PROSTATE 57(4):298-308
Witte JS; Suarez BK; Thiel B; Lin J; Yu A; et al.
Genome-wide scan of brothers: Replication and fine mapping of prostate cancer susceptibility and aggressiveness loci
05
2032113119 2004 EUROPEAN JOURNAL OF CANCER 40(17):2623-2632
Wulfkuhle J; Espina V; Liotta L; Petricoin E
Genomic and proteomic technologies for individualisation and improvement of cancer treatment
00
204112417 2003 CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT 6(3):384-395
Xiang ZY; Yang YN; Ma XJ; Ding W
Microarray expression profiling: Analysis and applications
18
20522161 2004 LABORATORY INVESTIGATION 84(4):395-396
Xu RL; Jaffer S
Is metastatic potential of breast cancer inherent or acquired?
00
20612513 2003 CANCER RESEARCH 63(22):7785-7790
Yamamoto N; Yang M; Jiang P; Xu MX; Tsuchiya H; et al.
Determination of clonality of metastasis by cell-specific color-coded fluorescent-protein imaging
04
20723697 2004 CELL 117(7):927-939
Yang J; Mani SA; Donaher JL; Ramaswamy S; Itzykson RA; et al.
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
113
20826480 2004 CANCER RESEARCH 64(6):1975-1986
Yegnasubramanian S; Kowalski J; Gonzalgo ML; Zahurak M; Piantadosi S; et al.
Hypermethylation of CpG islands in primary and metastatic human prostate cancer
112
20924493 2004 CANCER SCIENCE 95(3):197-204
Yokota J; Kohno T
Molecular footprints of human lung cancer progression
01
21012083 2004 CANCER RESEARCH 64(9):2962-2968
Yu K; Lee CH; Tan PH; Hong GS; Wee SB; et al.
A molecular signature of the Nottingham prognostic index in breast cancer
01
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
211145173 2004 NATURE MEDICINE 10(2):175-181
Yu YL; Khan J; Khanna C; Helman L; Meltzer PS; et al.
Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators
116
2121198103 2004 CELLULAR SIGNALLING 16(10):1085-1104
Zimber A; Nguyen QD; Gespach C
Nuclear bodies and compartments: Functional roles and cellular signalling in health and disease
02

Generated by: HistCite 2004.12.21